Readable HTML

English — reviewed original text

MCA-F-501/14, Version 1 – 24 January 2025 — Line Listing of Adverse Events and Serious Adverse Events

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

Link directly to a passage with its anchor — for example #pdf-page-1 — to open it highlighted. This reference version is generated from the authority’s publication and does not replace it. Language: English.

Contents

MEDICINES CONTROL AGENCY MCA THE GAMBIA LINE LISTING OF ADVERSE EVENTS (AES) & SERIOUS ADVERSE EVENTS (SAES) MCA-F-501/14 Protocol number: Title of Trial: Date of initial MCA approval: Name of PI Name of Coordinating Investigator (if applicable): Site(s)name/number: IMP: Period of reporting: PARTICIPANT ID REPORT DATE(s) SITE AGE/DOB (GENDER) IMP START DATE OF IMP EVENT DECRIPTION/ DIAGNOSIS DATE OF ONSET SAE CATEGORY (if applicable) AE CATEGORY (if applicable) OUTCOME RELATION- SHIP TO IMP Example 12/08/10 Initial 05 40yrs (F) AB 19/05/09 Angina 10/08/10 Hospitalised Died Not related MCA-F-501/14, Version 1 – 24 January 2025 Page 1 of 1

Original PDF page 1 — retained source fields, tables and layout.
Original PDF page 1 — retained source fields, tables and layout.